Skip to Content

Eastman Chemical Co

EMN: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$477.00LmmtblQqmmdyvq

Eastman Chemical Earnings: Volume Growth Supports Our Recovery Thesis

Eastman Chemical's first-quarter results showed demand was recovering in line with our outlook for the cadence of the year. Volumes rose 3% versus the prior-year quarter, following inventory destocking that weighed on 2023 results. In 2024, we think Eastman will generate higher profits, as customer inventory destocking will be largely completed by the end of the second quarter.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of EMN so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center